ArticleHeliyon2023

Therapeutic potential of single-nucleotide polymorphism-mediated interleukin-6 receptor blockade in cancer treatment: A Mendelian randomization study.

Shuwan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.